表紙:細胞増殖の世界市場-製品別・アプリケーション別・エンドユーザー別:機会分析および業界予測(2021年~2030年)
市場調査レポート
商品コード
1030068

細胞増殖の世界市場-製品別・アプリケーション別・エンドユーザー別:機会分析および業界予測(2021年~2030年)

Cell Expansion Market by Product, Application, and End User : Global Opportunity Analysis and Industry Forecast, 2021-2030.

出版日: | 発行: Allied Market Research | ページ情報: 英文 290 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=134.29円
細胞増殖の世界市場-製品別・アプリケーション別・エンドユーザー別:機会分析および業界予測(2021年~2030年)
出版日: 2021年07月01日
発行: Allied Market Research
ページ情報: 英文 290 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の細胞増殖市場規模は、2020年に130億6,620万米ドルに達しました。

2030年には390億3,110万米ドルに達するとみられ、2021年から2030年の間に11.6%のCAGRで成長すると予測されています。

細胞増殖市場の成長を促進する主な要因として、糖尿病、関節リウマチ、癌などの慢性疾患の発生率の増加が挙げられます。加えて、政府による細胞ベースの研究への投資や、細胞ベースの治療法の研究開発への注力が、市場の成長をさらに後押ししています。

しかし、細胞生物学の研究に対する倫理的な懸念、熟練した専門家の不足、細胞ベースの治療法の高コストなどが、市場の成長を抑制しています。一方で、新興市場での成長機会や個別化医療への注目度の高まりは、細胞増殖市場に有利な機会をもたらします。

当レポートでは、世界の細胞増殖市場について調査しており、市場情勢、市場力学、市場分析、企業プロファイルなど、包括的な情報を提供しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場の定義と範囲
  • 主な調査結果
    • 主な投資ポケット
    • 主な成功戦略
  • ポーターのファイブフォース分析
  • 主要企業のポジショニング(2020年)
  • 市場力学
    • 促進要因
      • 慢性疾患の有病率の増加
      • 細胞ベースの調査のための政府投資の急増
      • 細胞ベースの治療法の研究開発への焦点化
    • 抑制要因
      • 高い細胞ベースの治療のコスト
      • 熟練した専門家の不足
      • 細胞生物学の調査に関する倫理的懸念
    • 市場機会
      • 新興市場における機会の成長
      • 個別化医療への焦点化
    • 影響分析
  • 細胞増殖市場におけるCOVID-19の影響分析

第4章 細胞増殖市場:製品別

  • 概要
    • 市場規模と予測
  • 消耗品
    • 主要な市場動向、成長要因、および機会
    • 市場規模と予測:地域別
    • 市場分析:国別
  • 装置
    • 主要な市場動向、成長要因、および機会
    • 市場規模と予測
    • 市場分析:国別

第5章 細胞増殖市場:アプリケーション別

  • 概要
    • 市場規模と予測
  • 幹細胞技術
    • 主要な市場動向、成長要因、および機会
    • 市場規模と予測:地域別
    • 市場分析:国別
  • がん研究
    • 主要な市場動向、成長要因、および機会
    • 市場規模と予測
    • 市場分析:国別
  • 薬物のスクリーニングと開発
    • 主要な市場動向、成長要因、および機会
    • 市場規模と予測
    • 市場分析:国別
  • 組織工学と再生医療
    • 主要な市場動向、成長要因、および機会
    • 市場規模と予測
    • 市場分析:国別
  • その他
    • 主要な市場動向、成長要因、および機会
    • 市場規模と予測
    • 市場分析:国別

第6章 細胞増殖市場:エンドユーザー別

  • 概要
    • 市場規模と予測
  • 研究機関
    • 市場規模と予測:地域別
    • 市場分析:国別
    • 市場規模と予測:タイプ別
    • 消耗品
      • 市場規模と予測
    • 装置
      • 市場規模と予測
  • 製薬およびバイオテクノロジー企業
    • 市場規模と予測
    • 市場分析:国別
    • 市場規模と予測:タイプ別
    • 消耗品
      • 市場規模と予測
    • 装置
      • 市場規模と予測
  • その他
    • 市場規模と予測
    • 市場分析:国別
    • 市場規模と予測:タイプ別
    • 消耗品
      • 市場規模と予測
    • 装置
      • 市場規模と予測

第7章 細胞増殖市場:地域別

  • 概要
    • 市場規模と予測
  • 北米
    • 主要な市場動向、成長要因、および機会
    • 市場規模と予測:国別
      • 米国
      • カナダ
      • メキシコ
    • 北米の市場規模と予測:製品別
    • 北米の市場規模と予測:アプリケーション別
    • 北米の市場規模と予測:エンドユーザー別
      • 北米の研究機関市場:製品別
      • 北米の製薬およびバイオテクノロジー企業市場:製品別
      • 北米のその他の市場:製品別
  • 欧州
    • 主要な市場動向、成長要因、および機会
    • 市場規模と予測:国別
      • ドイツ
      • フランス
      • 英国
      • イタリア
      • スペイン
      • その他
    • 欧州の市場規模と予測:製品別
    • 欧州の市場規模と予測:アプリケーション別
    • 欧州の市場規模と予測:エンドユーザー別
      • 欧州の研究機関市場:製品別
      • 欧州の製薬およびバイオテクノロジー企業市場:製品別
      • 欧州のその他の市場:製品別
  • アジア太平洋
    • 主要な市場動向、成長要因、および機会
    • 市場規模と予測:国別
      • 日本
      • 中国
      • オーストラリア
      • インド
      • 韓国
      • その他
    • アジア太平洋市場の規模と予測:製品別
    • アジア太平洋市場の規模と予測:アプリケーション別
    • アジア太平洋市場の規模と予測:エンドユーザー別
      • アジア太平洋の研究機関市場:製品別
      • アジア太平洋の製薬およびバイオテクノロジー企業市場:製品別
      • アジア太平洋のその他の市場:製品別
  • ラテンアメリカ・中東・アフリカ
    • 主要な市場動向、成長要因、および機会
    • 市場規模と予測:国別
      • ブラジル
      • サウジアラビア
      • 南アフリカ
      • その他
    • ラテンアメリカ・中東・アフリカの市場規模と予測:製品別
    • ラテンアメリカ・中東・アフリカの市場規模と予測:アプリケーション別
    • ラテンアメリカ・中東・アフリカの市場規模と予測:エンドユーザー別
      • ラテンアメリカ・中東・アフリカの研究機関市場:製品別
      • ラテンアメリカ・中東・アフリカの製薬およびバイオテクノロジー企業市場:製品別
      • ラテンアメリカ・中東・アフリカのその他の市場:製品別

第8章 企業プロファイル

  • Becton, Dickinson, and Company
  • CORNING GROUP, INC.
  • DANAHER CORPORATION
  • EPPENDORF CORPORATE
  • HIMEDIA LABORATORIES
  • Lonza Group Ltd
  • Merck KGAA
  • PromoCell GmbH
  • SARTORIUS AG
  • THERMO FISHER SCIENTIFIC, INC.
図表

LIST OF TABLES

  • TABLE 01.GLOBAL CELL EXPANSION MARKET, BY PRODUCT, 2020-2030($MILLION)
  • TABLE 02.CONSUMABLES CELL EXPANSION MARKET, BY REGION, 2020-2030($MILLION)
  • TABLE 03.INSTRUMENTS CELL EXPANSION MARKET, BY REGION, 2020-2030($MILLION)
  • TABLE 04.GLOBAL CELL EXPANSION MARKET, BY APPLICATION, 2020-2030($MILLION)
  • TABLE 05.STEM CELL TECHNOLOGY CELL EXPANSION MARKET, BY REGION, 2020-2030($MILLION)
  • TABLE 06.CANCER RESEARCH CELL EXPANSION MARKET, BY REGION, 2020-2030($MILLION)
  • TABLE 07.DRUG SCREENING AND DEVELOPMENT CELL EXPANSION MARKET, BY REGION, 2020-2030($MILLION)
  • TABLE 08.TISSUE ENGINEERING & REGENERATIVE MEDICINE CELL EXPANSION MARKET, BY REGION, 2020-2030($MILLION)
  • TABLE 09.OTHERS CELL EXPANSION MARKET, BY REGION, 2020-2030($MILLION)
  • TABLE 10.CELL EXPANSION MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 11.RESEARCH INSTITUTES CELL EXPANSION MARKET, BY REGION, 2020-2030($MILLION)
  • TABLE 12.CELL EXPANSION MARKET, FOR RESEARCH INSTITUTE, BY TYPE, 2020-2030, ($MILLION)
  • TABLE 13.PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES CELL EXPANSION MARKET, BY REGION, 2020-2030($MILLION)
  • TABLE 14.CELL EXPANSION MARKET, FOR PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY TYPE, 2020-2030, ($MILLION)
  • TABLE 15.OTHERS CELL EXPANSION MARKET, BY REGION, 2020-2030($MILLION)
  • TABLE 16.CELL EXPANSION MARKET, FOR OTHERS, BY TYPE, 2020-2030, ($MILLION)
  • TABLE 17.CELL EXPANSION MARKET, BY REGION, 2020-2030($MILLION)
  • TABLE 18.NORTH AMERICA CELL EXPANSION MARKET, BY COUNTRY, 2020-2030($MILLION)
  • TABLE 19.U.S. CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
  • TABLE 20.U.S. CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
  • TABLE 21.U.S. CELL EXPANSION MARKET, BY END USER, 2020-2030
  • TABLE 22.CANADA CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
  • TABLE 23.CANADA CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
  • TABLE 24.CANADA CELL EXPANSION MARKET, BY END USER, 2020-2030
  • TABLE 25.MEXICO CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
  • TABLE 26.MEXICO CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
  • TABLE 27.MEXICO CELL EXPANSION MARKET, BY END USER, 2020-2030
  • TABLE 28.NORTH AMERICA CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
  • TABLE 29.NORTH AMERICA CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
  • TABLE 30.NORTH AMERICA CELL EXPANSION MARKET, BY END USER, 2020-2030
  • TABLE 31.NORTH AMERICA RESEARCH INSTITUTES MARKET, BY PRODUCT, 2020-2030
  • TABLE 32.NORTH AMERICA PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, BY PRODUCT, 2020-2030
  • TABLE 33.NORTH AMERICA OTHERS MARKET, BY PRODUCT, 2020-2030
  • TABLE 34.EUROPE CELL EXPANSION MARKET, BY COUNTRY, 2020-2030($MILLION)
  • TABLE 35.GERMANY CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
  • TABLE 36.GERMANY CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
  • TABLE 37.GERMANY CELL EXPANSION MARKET, BY END USER, 2020-2030
  • TABLE 38.FRANCE CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
  • TABLE 39.FRANCE CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
  • TABLE 40.FRANCE CELL EXPANSION MARKET, BY END USER, 2020-2030
  • TABLE 41.UK CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
  • TABLE 42.UK CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
  • TABLE 43.UK CELL EXPANSION MARKET, BY END USER, 2020-2030
  • TABLE 44.ITALY CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
  • TABLE 45.ITALY CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
  • TABLE 46.ITALY CELL EXPANSION MARKET, BY END USER, 2020-2030
  • TABLE 47.SPAIN CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
  • TABLE 48.SPAIN CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
  • TABLE 49.SPAIN CELL EXPANSION MARKET, BY END USER, 2020-2030
  • TABLE 50.REST OF EUROPE CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
  • TABLE 51.REST OF EUROPE CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
  • TABLE 52.REST OF EUROPE CELL EXPANSION MARKET, BY END USER, 2020-2030
  • TABLE 53.EUROPE CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
  • TABLE 54.EUROPE CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
  • TABLE 55.EUROPE CELL EXPANSION MARKET, BY END USER, 2020-2030
  • TABLE 56.EUROPE RESEARCH INSTITUTES MARKET, BY PRODUCT, 2020-2030
  • TABLE 57.EUROPE PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, BY PRODUCT, 2020-2030
  • TABLE 58.EUROPE OTHERS MARKET, BY PRODUCT, 2020-2030
  • TABLE 59.ASIA-PACIFIC CELL EXPANSION MARKET, BY COUNTRY, 2020-2030($MILLION)
  • TABLE 60.JAPAN CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
  • TABLE 61.JAPAN CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
  • TABLE 62.JAPAN CELL EXPANSION MARKET, BY END USER, 2020-2030
  • TABLE 63.CHINA CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
  • TABLE 64.CHINA CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
  • TABLE 65.CHINA CELL EXPANSION MARKET, BY END USER, 2020-2030
  • TABLE 66.AUSTRALIA CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
  • TABLE 67.AUSTRALIA CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
  • TABLE 68.AUSTRALIA CELL EXPANSION MARKET, BY END USER, 2020-2030
  • TABLE 69.INDIA CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
  • TABLE 70.INDIA CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
  • TABLE 71.INDIA CELL EXPANSION MARKET, BY END USER, 2020-2030
  • TABLE 72.SOUTH KOREA CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
  • TABLE 73.SOUTH KOREA CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
  • TABLE 74.SOUTH KOREA CELL EXPANSION MARKET, BY END USER, 2020-2030
  • TABLE 75.REST OF ASIA-PACIFIC CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
  • TABLE 76.REST OF ASIA-PACIFIC CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
  • TABLE 77.REST OF ASIA-PACIFIC CELL EXPANSION MARKET, BY END USER, 2020-2030
  • TABLE 78.ASIA-PACIFIC CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
  • TABLE 79.ASIA-PACIFIC CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
  • TABLE 80.ASIA-PACIFIC CELL EXPANSION MARKET, BY END USER, 2020-2030
  • TABLE 81.ASIA-PACIFIC RESEARCH INSTITUTES MARKET, BY PRODUCT, 2020-2030
  • TABLE 82.ASIA-PACIFIC PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, BY PRODUCT, 2020-2030
  • TABLE 83.ASIA-PACIFIC OTHERS MARKET, BY PRODUCT, 2020-2030
  • TABLE 84.LAMEA CELL EXPANSION MARKET, BY COUNTRY, 2020-2030($MILLION)
  • TABLE 85.BRAZIL CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
  • TABLE 86.BRAZIL CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
  • TABLE 87.BRAZIL CELL EXPANSION MARKET, BY END USER, 2020-2030
  • TABLE 88.SAUDI ARABIA CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
  • TABLE 89.SAUDI ARABIA CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
  • TABLE 90.SAUDI ARABIA CELL EXPANSION MARKET, BY END USER, 2020-2030
  • TABLE 91.SOUTH AFRICA CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
  • TABLE 92.SOUTH AFRICA CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
  • TABLE 93.SOUTH AFRICA CELL EXPANSION MARKET, BY END USER 2020-2030
  • TABLE 94.REST OF LAMEA CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
  • TABLE 95.REST OF LAMEA CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
  • TABLE 96.REST OF LAMEA CELL EXPANSION MARKET, END USER, 2020-2030
  • TABLE 97.LAMEA CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
  • TABLE 98.LAMEA CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
  • TABLE 99.LAMEA CELL EXPANSION MARKET, BY END USER, 2020-2030
  • TABLE 100.LAMEA RESEARCH INSTITUTES, BY PRODUCT, 2020-2030
  • TABLE 101.LAMEA PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY PRODUCT, 2020-2030
  • TABLE 102.LAMEA OTHERS MARKET, BY PRODUCT, 2020-2030
  • TABLE 103.BD: COMPANY SNAPSHOT
  • TABLE 104.BD: OPERATING SEGMENTS
  • TABLE 105.BD: PRODUCT PORTFOLIO
  • TABLE 106.CORNING: COMPANY SNAPSHOT
  • TABLE 107.CORNING: OPERATING SEGMENTS
  • TABLE 108.CORNING: PRODUCT PORTFOLIO
  • TABLE 109.DANAHER: SNAPSHOT
  • TABLE 110.DANAHER: OPERATING SEGMENTS
  • TABLE 111.DANAHER: PRODUCT PORTFOLIO
  • TABLE 112.EPPENDORF: COMPANY SNAPSHOT
  • TABLE 113.EPPENDORF: OPERATING SEGMENTS
  • TABLE 114.EPPENDORF: PRODUCT PORTFOLIO
  • TABLE 115.HIMEDIA: COMPANY SNAPSHOT
  • TABLE 116.HIMEDIA: OPERATING SEGMENTS
  • TABLE 117.HIMEDIA: PRODUCT PORTFOLIO
  • TABLE 118.LONZA: COMPANY SNAPSHOT
  • TABLE 119.LONZA: OPERATING SEGMENTS:
  • TABLE 120.LONZA: PRODUCT PORTFOLIO
  • TABLE 121.MERCK: COMPANY SNAPSHOT
  • TABLE 122.MERCK: OPERATING SEGMENTS
  • TABLE 123.MERCK: PRODUCT PORTFOLIO
  • TABLE 124.PROMOCELL: COMPANY SNAPSHOT
  • TABLE 125.PROMOCELL: OPERATING SEGMENTS
  • TABLE 126.PROMOCELL: PRODUCT PORTFOLIO
  • TABLE 127.SARTORIUS: COMPANY SNAPSHOT
  • TABLE 128.SARTORIUS: OPERATING SEGMENTS
  • TABLE 129.SARTORIUS: PRODUCT PORTFOLIO
  • TABLE 130.SARTORIUS: KEY DEVELOPMENTS
  • TABLE 131.THERMO FISCHER: COMPANY SNAPSHOT
  • TABLE 132.THERMO FISCHER: OPERATING SEGMENTS
  • TABLE 133.THERMO FISCHER: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01.GLOBAL CELL EXPANSION MARKET SEGMENTATION
  • FIGURE 02.TOP INVESTMENT POCKETS
  • FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2019-2021
  • FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019-2021
  • FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2019-2021
  • FIGURE 01.MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 02.MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 03.MODERATE THREAT OF SUBSTITUTES
  • FIGURE 04.LOW THREAT OF NEW ENTRANTS
  • FIGURE 05.HIGH INTENSITY OF RIVALRY
  • FIGURE 06.TOP PLAYER POSITIONING, 2020
  • FIGURE 07.IMPACT ANALYSIS
  • FIGURE 08.COMPARATIVE ANALYSIS OF CONSUMABLES CELL EXPANSION MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
  • FIGURE 09.COMPARATIVE ANALYSIS OF INSTRUMENTS CELL EXPANSION MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
  • FIGURE 10.COMPARATIVE ANALYSIS OF STEM CELL TECHNOLOGY CELL EXPANSION MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
  • FIGURE 11.COMPARATIVE ANALYSIS OF CANCER RESEARCH CELL EXPANSION MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
  • FIGURE 12.COMPARATIVE ANALYSIS OF DRUG SCREENING AND DEVELOPMENT CELL EXPANSION MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
  • FIGURE 13.COMPARATIVE ANALYSIS OF TISSUE ENGINEERING & REGENERATIVE MEDICINE CELL EXPANSION MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
  • FIGURE 14.COMPARATIVE ANALYSIS OF OTHERS CELL EXPANSION MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
  • FIGURE 15.COMPARATIVE ANALYSIS OF RESEARCH INSTITUTES CELL EXPANSION MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
  • FIGURE 16.CONSUMABLES CELL EXPANSION MARKET, 2020-2030, ($MILLION)
  • FIGURE 17.INSTRUMENTS CELL EXPANSION MARKET, 2020-2030, ($MILLION)
  • FIGURE 18.COMPARATIVE ANALYSIS OF PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES CELL EXPANSION MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
  • FIGURE 19.CONSUMABLES CELL EXPANSION MARKET, 2020-2030, ($MILLION)
  • FIGURE 20.INSTRUMENTS CELL EXPANSION MARKET, 2020-2030, ($MILLION)
  • FIGURE 21.COMPARATIVE ANALYSIS OF OTHERS CELL EXPANSION MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
  • FIGURE 22.CONSUMABLES CELL EXPANSION MARKET, 2020-2030, ($MILLION)
  • FIGURE 23.INSTRUMENTS CELL EXPANSION MARKET, 2020-2030, ($MILLION)
  • FIGURE 24.CANCER INCIDENCES IN GERMANY (2007 & 2050)
  • FIGURE 25.BD: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 26.BD: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 27.BD: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 28.CORNING: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 29.CORNING: REVENUE SHARE BY SEGMENT, 2019 (%)
  • FIGURE 30.CORNING: REVENUE SHARE BY REGION, 2019 (%)
  • FIGURE 31.DANAHER: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 32.DANAHER: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 33.DANAHER: REVENUE SHARE BY REGION, 2019 (%)
  • FIGURE 34.EPPENDORF: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 35.EPPENDORF: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 36.EPPENDORF: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 37.LONZA: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 38.LONZA: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 39.LONZA: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 40.MERCK: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 41.MERCK: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 42.MERCK: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 43.SARTORIUS: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 44.SARTORIUS: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 45.SARTORIUS: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 46.NET SALES, 2018-2020 ($MILLION)
  • FIGURE 47.THERMO FISCHER: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 48.THERMO FISCHER: REVENUE SHARE BY REGION, 2020 (%)
目次
Product Code: A03231

The global cell expansion market was valued at $13,066.2 million in 2020, and is projected to reach $39,031.1 million by 2030, registering a CAGR of 11.6% from 2021 to 2030.

Cell expansion deals with the production of daughter cells that arise from single cell. Cell expansion process is used in therapeutic development, drug screening, and microlevel research of cells. Presently, cell expansion is widely used to improve transplantation and in the treatment of various diseases such as rheumatoid arthritis, diabetes, cancer, and others. Cell expansion require an appropriate culturing environment for successful cell development. Culturing environment is maintained utilizing culture media, supplements for growth, and reagents. Cell expansion systems also ensure to simplify the overall task and to reduce labor-intensive manual tasks, which are associated with the process.

The main factor that drives the growth of the cell expansion market include increase in incidences of chronic diseases such as diabetes, rheumatoid arthritis, and cancer. In addition, government investments for cell-based research and increase in focus on R&D for cell-based therapies further boost the growth of the market. However, ethical concerns regarding research in cell biology, dearth of skilled professionals, and high cost of cell-based therapies restrain the growth of the market. In contrast, growth opportunity in emerging markets and growth in focus on personalized medicine create lucrative opportunities for the cell expansion market.

The global cell expansion market is segmented on the basis of product, application, end user, and region to provide a detailed assessment of the market. By product, the market is divided into instruments and consumables. By application, the market is classified into stem cell technology, cancer research, drug screening & development, tissue engineering & regenerative medicine, and others. By end user, it is divided into research institutes, pharmaceutical & biotechnology companies, and academic institutes. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Major players operating in the market include Becton, Dickinson and Company, Corning Incorporated, Eppendorf, Sartorius AG, Merck KGaA, Lonza Group AG, PromoCell GmbH, Danaher Corporation, Thermo Fisher Scientific, and HiMedia Laboratories.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the cell expansion market along with the current trends and future estimations to explain the imminent investment pockets.
  • A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
  • Comprehensive quantitative analysis of the industry from 2020 to 2028 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the key segments of the industry helps to understand the application and products of cell expansion used across the globe.
  • Key market players and their strategies have been analyzed to understand the competitive outlook of the market.

KEY MARKET SEGMENTS

By Product

  • Consumables
  • Instruments

By Application

  • Stem Cell Technology
  • Cancer Research
  • Drug Screening and Development
  • Tissue Engineering & Regenerative Medicine
  • Others

By End User

  • Research Institutes
  • Consumables
  • Instruments
  • Pharmaceutical & Biotechnology Companies
  • Consumables
  • Instruments
  • Others
  • Consumables
  • Instruments

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

  • Becton, Dickinson and Company
  • Corning Incorporated
  • Eppendorf, Sartorius AG
  • Merck KGaA
  • Lonza Group AG
  • PromoCell GmbH
  • Danaher Corporation
  • Thermo Fisher Scientific
  • HiMedia Laboratories

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key Benefits for Stakeholders
  • 1.3.Key market segments
    • 1.3.1.List of key players profiled in the report
  • 1.4.Research methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
    • 3.2.2.Top winning strategies
  • 3.3.Porter's five force analysis
  • 3.4.Top player positioning, 2020
  • 3.5.Market dynamics
    • 3.5.1.Drivers
      • 3.5.1.1.Increase in prevalence of chronic diseases
      • 3.5.1.2.Surge in government investments for cell-based research
      • 3.5.1.3.Rise in focus on R&D for cell-based therapies
    • 3.5.2.Restraints
      • 3.5.2.1.High cost of cell-based therapies
      • 3.5.2.2.Dearth of skilled professionals
      • 3.5.2.3.Ethical concerns regarding research in cell biology
    • 3.5.3.Opportunities
      • 3.5.3.1.Growth in opportunities in emerging markets
      • 3.5.3.2.Rise in focus on personalized medicine
    • 3.5.4.Impact analysis
  • 3.6.COVID-19 impact analysis on the cell expansion market

CHAPTER 4:CELL EXPANSION MARKET, BY PRODUCT

  • 4.1.Overview
    • 4.1.1.Market size and forecast
  • 4.2.Consumables
    • 4.2.1.Key market trends, growth factors, and opportunities
    • 4.2.2.Market size and forecast, by region
    • 4.2.3.Market analysis, by country
  • 4.3.Instruments
    • 4.3.1.Key market trends, growth factors, and opportunities
    • 4.3.2.Market size and forecast
    • 4.3.3.Market analysis, by country

CHAPTER 5:CELL EXPANSION MARKET, BY APPLICATION

  • 5.1.Overview
    • 5.1.1.Market size and forecast
  • 5.2.Stem cell technology
    • 5.2.1.Key market trends, growth factors, and opportunities
    • 5.2.2.Market size and forecast, by region
    • 5.2.3.Market analysis, by country
  • 5.3.Cancer research
    • 5.3.1.Key market trends, growth factors, and opportunities
    • 5.3.2.Market size and forecast
    • 5.3.3.Market analysis, by country
  • 5.4.Drug screening & development
    • 5.4.1.Key market trends, growth factors, and opportunities
    • 5.4.2.Market size and forecast
    • 5.4.3.Market analysis, by country
  • 5.5.Tissue engineering & regenerative medicine
    • 5.5.1.Key market trends, growth factors, and opportunities
    • 5.5.2.Market size and forecast
    • 5.5.3.Market analysis, by country
  • 5.6.Others
    • 5.6.1.Key market trends, growth factors, and opportunities
    • 5.6.2.Market size and forecast
    • 5.6.3.Market analysis, by country

CHAPTER 6:CELL EXPANSION MARKET, BY END USER

  • 6.1.Overview
    • 6.1.1.Market size and forecast
  • 6.2.Research institutes
    • 6.2.1.Market size and forecast, by region
    • 6.2.2.Market analysis, by country
    • 6.2.3.Market size and forecast, by type
    • 6.2.4.Consumables
      • 6.2.4.1.Market size and forecast
    • 6.2.5.Instruments
      • 6.2.5.1.Market size and forecast
  • 6.3.Pharmaceutical & biotechnology companies
    • 6.3.1.Market size and forecast
    • 6.3.2.Market analysis, by country
    • 6.3.3.Market size and forecast, by type
    • 6.3.4.Consumables
      • 6.3.4.1.Market size and forecast
    • 6.3.5.Instruments
      • 6.3.5.1.Market size and forecast
  • 6.4.Others
    • 6.4.1.Market size and forecast
    • 6.4.2.Market analysis, by country
    • 6.4.3.Market size and forecast, by type
    • 6.4.4.Consumables
      • 6.4.4.1.Market size and forecast
    • 6.4.5.Instruments
      • 6.4.5.1.Market size and forecast

CHAPTER 7:CELL EXPANSION MARKET, BY REGION

  • 7.1.Overview
    • 7.1.1.Market size and forecast
  • 7.2.North America
    • 7.2.1.Key market trends, growth factors, and opportunities
    • 7.2.2.Market size and forecast, by country
      • 7.2.2.1.U.S.
      • 7.2.2.1.1.U.S. cell expansion market, by product
      • 7.2.2.1.2.U.S. Cell expansion market, by application
      • 7.2.2.1.3.U.S. Cell expansion market, by end user
      • 7.2.2.2.Canada
      • 7.2.2.2.1.Canada Cell expansion market, by product
      • 7.2.2.2.2.Canada Cell expansion market, by application
      • 7.2.2.2.3.Canada Cell expansion market, by end user
      • 7.2.2.3.Mexico
      • 7.2.2.3.1.Mexico Cell expansion market, by product
      • 7.2.2.3.2.Mexico Cell expansion market, by application
      • 7.2.2.3.3.Mexico Cell expansion market, by end user
    • 7.2.3.North America market size and forecast, by product
    • 7.2.4.North America market size and forecast, by application
    • 7.2.5.North America market size and forecast, by end user
      • 7.2.5.1.North America research institutes market, by product
      • 7.2.5.2.North America pharmaceutical & biotechnology companies market, by product
      • 7.2.5.3.North America others market, by product
  • 7.3.Europe
    • 7.3.1.Key market trends, growth factors, and opportunities
    • 7.3.2.Market size and forecast, by country
      • 7.3.2.1.Germany
      • 7.3.2.1.1.Germany Cell expansion market, by product
      • 7.3.2.1.2.Germany Cell expansion market, by application
      • 7.3.2.1.3.Germany Cell expansion market, by end user
      • 7.3.2.2.France
      • 7.3.2.2.1.France Cell expansion market, by product
      • 7.3.2.2.2.France Cell expansion market, by application
      • 7.3.2.2.3.France Cell expansion market, by end user
      • 7.3.2.3.UK
      • 7.3.2.3.1.UK Cell expansion market, by product
      • 7.3.2.3.2.UK Cell expansion market, by application
      • 7.3.2.3.3.UK Cell expansion market, by end user
      • 7.3.2.4.Italy
      • 7.3.2.4.1.Italy Cell expansion market, by product
      • 7.3.2.4.2.Italy Cell expansion market, by application
      • 7.3.2.4.3.Italy Cell expansion market, by end user
      • 7.3.2.5.Spain
      • 7.3.2.5.1.Spain Cell expansion market, by product
      • 7.3.2.5.2.Spain Cell expansion market, by application
      • 7.3.2.5.3.Spain Cell expansion market, by end user
      • 7.3.2.6.Rest of Europe
      • 7.3.2.6.1.Rest of Europe Cell expansion market, by product
      • 7.3.2.6.2.Rest of Europe Cell expansion market, by application
      • 7.3.2.6.3.Rest of Europe Cell expansion market, by end user
    • 7.3.3.Europe market size and forecast, by product
    • 7.3.4.Europe market size and forecast, by application
    • 7.3.5.Europe market size and forecast, by end user
      • 7.3.5.1.Europe research institutes market, by product
      • 7.3.5.2.Europe pharmaceutical & biotechnology companies market, by product
      • 7.3.5.3.Europe others market, by product
  • 7.4.Asia-Pacific
    • 7.4.1.Key market trends, growth factors, and opportunities
    • 7.4.2.Market size and forecast, by country
      • 7.4.2.1.Japan
      • 7.4.2.1.1.Japan Cell expansion market, by product
      • 7.4.2.1.2.Japan Cell expansion market, by application
      • 7.4.2.1.3.Japan Cell expansion market, by end user
      • 7.4.2.2.China
      • 7.4.2.2.1.China Cell expansion market, by product
      • 7.4.2.2.2.China Cell expansion market, by application
      • 7.4.2.2.3.China Cell expansion market, by end user
      • 7.4.2.3.Australia
      • 7.4.2.3.1.Australia Cell expansion market, by product
      • 7.4.2.3.2.Australia Cell expansion market, by application
      • 7.4.2.3.3.Australia Cell expansion market, by end user
      • 7.4.2.4.India
      • 7.4.2.4.1.India Cell expansion market, by product
      • 7.4.2.4.2.India Cell expansion market, by application
      • 7.4.2.4.3.India Cell expansion market, by end user
      • 7.4.2.5.South Korea
      • 7.4.2.5.1.South Korea Cell expansion market, by product
      • 7.4.2.5.2.South Korea Cell expansion market, by application
      • 7.4.2.5.3.South Korea Cell expansion market, by end user
      • 7.4.2.6.Rest of Asia-Pacific
      • 7.4.2.6.1.Rest of Asia-Pacific Cell expansion market, by product
      • 7.4.2.6.2.Rest of Asia-Pacific Cell expansion market, by application
      • 7.4.2.6.3.Rest of Asia-Pacific Cell expansion market, by end user
    • 7.4.3.Asia-Pacific market size and forecast, by product
    • 7.4.4.Asia-Pacific market size and forecast, by application
    • 7.4.5.Asia-Pacific market size and forecast, by end user
      • 7.4.5.1.Asia-Pacific Research Institutes market, by product
      • 7.4.5.2.Asia-Pacific pharmaceutical & biotechnology companies market, by product
      • 7.4.5.3.Asia-Pacific others market, by product
  • 7.5.LAMEA
    • 7.5.1.Key market trends, growth factors, and opportunities
    • 7.5.2.Market size and forecast, by country
      • 7.5.2.1.Brazil
      • 7.5.2.1.1.Brazil Cell expansion market, by product
      • 7.5.2.1.2.Brazil Cell expansion market, by application
      • 7.5.2.1.3.Brazil Cell expansion market, by end user
      • 7.5.2.2.Saudi Arabia
      • 7.5.2.2.1.Saudi Arabia Cell expansion market, by product
      • 7.5.2.2.2.Saudi Arabia Cell expansion market, by application
      • 7.5.2.2.3.Saudi Arabia Cell expansion market, by end user
      • 7.5.2.3.South Africa
      • 7.5.2.3.1.South Africa Cell expansion market, by product
      • 7.5.2.3.2.South Africa Cell expansion market, by application
      • 7.5.2.3.3.South Africa Cell expansion market, by end user
      • 7.5.2.4.Rest of LAMEA
      • 7.5.2.4.1.Rest of LAMEA Cell expansion market, by product
      • 7.5.2.4.2.Rest of LAMEA Cell expansion market, by application
      • 7.5.2.4.3.Rest of LAMEA Cell expansion market, by end user
    • 7.5.3.LAMEA market size and forecast, by product
    • 7.5.4.LAMEA market size and forecast, by application
    • 7.5.5.LAMEA market size and forecast, by end user
      • 7.5.5.1.LAMEA Research Institutes market, by product
      • 7.5.5.2.LAMEA pharmaceutical & biotechnology companies market, by product
      • 7.5.5.3.LAMEA others market, by product

CHAPTER 8:COMPANY PROFILES

  • 8.1.Becton, Dickinson, and Company
    • 8.1.1.Company overview
    • 8.1.2.Operating business segments
    • 8.1.3.Product portfolio
    • 8.1.4.Business performance
  • 8.2.CORNING GROUP, INC.
    • 8.2.1.Company overview
    • 8.2.2.Operating business segments
    • 8.2.3.Product portfolio
    • 8.2.4.Business performance
    • 8.2.5.Key strategic moves and developments
  • 8.3.DANAHER CORPORATION
    • 8.3.1.Company overview
    • 8.3.2.Company snapshot
    • 8.3.3.Operating business segments
    • 8.3.4.Product portfolio
    • 8.3.5.Business performance
    • 8.3.6.Key strategic moves and developments
  • 8.4.EPPENDORF CORPORATE
    • 8.4.1.Company overview
    • 8.4.2.Operating business segments
    • 8.4.3.Product portfolio
    • 8.4.4.Business performance
    • 8.4.5.Key strategic moves and developments
  • 8.5.HIMEDIA LABORATORIES
    • 8.5.1.Company overview
    • 8.5.2.Operating business segments
    • 8.5.3.Product portfolio
    • 8.5.4.Key strategic moves and developments
  • 8.6.Lonza Group Ltd
    • 8.6.1.Company overview
    • 8.6.2.Operating business segments
    • 8.6.3.Product portfolio
    • 8.6.4.Business performance
    • 8.6.5.Key strategic moves and developments
  • 8.7.Merck KGAA
    • 8.7.1.Company overview
    • 8.7.2.Operating business segments
    • 8.7.3.Product portfolio
    • 8.7.4.Business performance
  • 8.8.PromoCell GmbH
    • 8.8.1.Company overview
    • 8.8.2.Operating business segments
    • 8.8.3.Product portfolio
  • 8.9.SARTORIUS AG
    • 8.9.1.Company overview
    • 8.9.2.Operating business segments
    • 8.9.3.Product portfolio
    • 8.9.4.Business performance
    • 8.9.5.Key strategic moves and developments
  • 8.10.THERMO FISHER SCIENTIFIC, INC.
    • 8.10.1.Company overview
    • 8.10.2.Operating business segments
    • 8.10.3.Product portfolio
    • 8.10.4.Business performance
    • 8.10.5.Key strategic moves and developments